Skandinaviska Enskilda Banken (SEB)
ONCE

Skandinaviska Enskilda Banken (SEB)’s Spark Therapeutics, Inc. Common Stock ONCE Stock Holding History

Skandinaviska Enskilda Banken (SEB)’s Portfolio ONCE Stock Details ONCE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-40,000
Closed -$3.88M – 978
2019
Q3 		$3.88M Buy
+40,000
New +$4.01M 0.03% 372

Skandinaviska Enskilda Banken (SEB)'s ONCE Position: Q4 2019 in Review

Skandinaviska Enskilda Banken (SEB) sold out of Spark Therapeutics, Inc. Common Stock (ONCE) in Q4 2019, closing a stake of 40,000 shares — an estimated $3.88M sold.

Skandinaviska Enskilda Banken (SEB) first reported a position in ONCE in Q3 2019 and held it in 1 quarter. The position peaked at $3.88M in Q3 2019. 0 funds tracked by Wall St. Rank hold ONCE as of Q4 2019.

  • Skandinaviska Enskilda Banken (SEB) reported no remaining Spark Therapeutics, Inc. Common Stock position as of Q4 2019 after selling out during the quarter.
  • Skandinaviska Enskilda Banken (SEB) sold 40,000 Spark Therapeutics, Inc. Common Stock shares in Q4 2019, an estimated $3.88M.
  • Skandinaviska Enskilda Banken (SEB) first reported a position in Spark Therapeutics, Inc. Common Stock in Q3 2019 and held it in 1 quarter.
  • Skandinaviska Enskilda Banken (SEB)'s Spark Therapeutics, Inc. Common Stock position peaked at $3.88M in Q3 2019.
  • 0 funds tracked by Wall St. Rank held Spark Therapeutics, Inc. Common Stock as of Q4 2019.

Based on Skandinaviska Enskilda Banken (SEB)'s 13F filing for Q4 2019, filed 14 Feb 2020.